We also detected the expression levels of MMP2 and MMP9 in NSCLC and SCLC patients, and it was showed that MMP2 and MMP9 expression levels in patients after treatment were significantly decreased (P <  0.05) (Figure S1C-D). The gene discussed is MMP2; the disease is non-small cell lung carcinoma.